Blepharitis Therapeutics Pipeline Review 2016 – 6 Companies & Drug Profiles – Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Blepharitis - Pipeline Review, H2 2016" drug pipelines to their offering. 'Blepharitis - Pipeline Review, H2 2016'; Blepharitis pipeline therapeutics constitutes close to 8 molecules. Out of which approximately 8 molecules are developed by Companies. Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin, blockage of the eyelid's oil glands